检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:杜金锋[1] 裴广德[1] 熊伟[1] 甄希[1] 杜军波[1] 汪光明[1]
机构地区:[1]河南省焦作市焦作煤业(集团)有限责任公司中央医院门诊部皮肤科,河南焦作454000
出 处:《河北医学》2013年第12期1764-1767,共4页Hebei Medicine
摘 要:目的:观察异维A酸红霉素凝胶联合螺内酯治疗寻常型痤疮的疗效和安全性。方法:将入选的147例轻、中度寻常型痤疮患者随机分为治疗组和对照组,两组均在睡前外用异维A酸红霉素凝胶1次,疗程8周;治疗组同时还予螺内酯片,20mg,tid与餐同服。在治疗2、4和8周后观察疗效和不良反应。结果:治疗2周后,两组的有效率分别为20.83%和14.29%,差异无统计学意义(P>0.05);4、8周后,治疗组有效率(54.17%,80.56%)均显著高于对照组(30.00%,54.29%),差异均有统计学意义(P<0.01)。药物相关不良反应主要为局部刺激症状,两组发生率分别为31.08%、29.58%,差异无统计学意义(P>0.05)。结论:异维A酸红霉素凝胶联合螺内酯治疗轻、中度寻常型痤疮疗效肯定、安全、不良反应少,价格低廉,值得推广应用。Objective: To evaluate the efficacy and safety of isotretinoin erythromycin gel united spironolactone in acne vulgaris. Method: 147 patients with the mild or moderate acne vulgaris were randomly divided into treatment group (n = 75 } and control group( n =72). They were topically treated with isotretinoin erythromycin gel once daily in the evening for 8 weeks, while the treatment group were treated with spironolactone,29mg was taken orally with the meal,3 times per day. And they were followed up on the 2,4,8 weeks after starting treatment. Result: The response rates of two groups were 20.83% and 14.29% respectively within 2 weeks after treatment, and there was no statistical significance ( P〉0.05 }. The effectiveness rates for the treatment group{ 54.17% ,80.56% ) were significantly higher than those in control roup { 30.00% ,54.29% ) within 4 and 8weeks respectively ( P〈O. O1 ). The drug related adverse reactions mainly is local irritation symptoms ,and the incidence was 31. 08% ,29.58% respectively,there was no statistically significant difference between the two groups. Conclusion: The treatment of isotretinoin erythromycin gel united spironolactone is effective, safe, with less adverse reaction and lower price, It's worth pop- ularizing and applying in the mild or moderate acne vulgaris.
分 类 号:R758.733[医药卫生—皮肤病学与性病学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.117